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Edited by Beat ImhofAbstract We previously demonstrated that monocytes produce
IL-23 during Francisella infection, and that IL-23 induces IFNc
from NK cells. Here, we demonstrate that IFNc-priming of
monocytes enhances IL-23 production during Francisella infec-
tion. This eﬀect was seen on the IL12/23 p40 subunit. Induction
of IL-12/23 p40 is reported to be enhanced by IRF-1 and IRF-8.
Consistently, microarray analysis of IFNc-treated monocytes re-
vealed a signiﬁcant induction of the IRFs. Interestingly, IFNc-
primed monocytes produced IL-12 p70, a more potent inducer
of IFNc than IL-23. We propose that there exists an ampliﬁca-
tion loop between monocyte IL-23 and NK/T cell IFNc that
leads to IL-12 p70 production.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Francisella tularensis, a gram-negative facultative bacterium,
is the causative agent of tularemia. The Type A subspecies F.
tularensis tularensis is classiﬁed as a Category A agent because
of the low dosage required for lethality [1].
Francisella infects primarily monocytes and macrophages
[2], and has the ability to escape from the host cell phagosome
and replicate in the cytoplasm. The subspecies F. novicida is
commonly used as an infection model because it is non-viru-
lent in normal humans yet leads to fatal tularemia in mouse
models [3]. Further, F. novicida follows the same intracellular
lifestyle in human monocytes/macrophages as the virulent F.
tularensis tularensis subspecies [4].
Host cell response to Francisella infection involves the re-
lease of multiple inﬂammatory cytokines, which oﬀer protec-
tion against the pathogen [5–10]. We have shown that F.
novicida elicits IL-23 production in human monocytes and that
the IL-23 could induce an IFNc response from NK cells [10].
IFNc has been shown to prime monocytes/macrophages to
produce enhanced levels of IL-12 in response to a subsequent
stimulus such as lipopolysaccharide [11]. Priming with IFNc
has also been recently shown to confer protection against
Francisella by promoting phagolysosome fusion and impeding
phagosomal escape [4].*Corresponding author.
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doi:10.1016/j.febslet.2008.02.058Here, we show that IL-23 production is strengthened by
IFNc, and that Francisella elicits IL-12 p70 from monocytes
only in the presence of suﬃcient IFNc.2. Materials and methods
2.1. Cells, antibodies and reagents
THP-1 cells were obtained from American Type Culture Collection
(Manassas, VA) and maintained in RPMI 1640 supplemented with
10% fetal bovine serum. CD14-positive peripheral blood monocytes
(PBM) were isolated as previously described [12].
2.2. Cell stimulation, lysis and Western blotting
PBM/THP-1 cells were infected with 100 MOI F. novicida or F.
tularensis LVS. The multiplicity of infection (MOI) was approximated
by measuring the optical density at 600 nm and conﬁrmed by plating
the inocula and counting CFU [6]. Uninfected and infected cells were
lysed in TN1 buﬀer (50 mM Tris pH 8.0, 10 mM EDTA, 10 mM
Na4P2O7, 10 mM NaF, 1% Triton-X 100, 125 mM NaCl, 10 mM
Na3VO4, 10 lg/ml each aprotinin and leupeptin). Post-nuclear lysates
were boiled in Laemmli Sample Buﬀer and were separated by SDS/
PAGE, transferred to nitrocellulose ﬁlters, probed with the antibody
of interest and developed by enhanced chemiluminescence (ECL,
Amersham).
2.3. Measurement of cytokines by ELISA
Cell supernatants were analyzed by ELISA using cytokine speciﬁc
kits from eBioscience (San Diego, CA) and R&D Systems (Minneap-
olis, MN).
2.4. Flow cytometry analysis of TLR2 expression
HP-1 cells were tested for the expression of TLR2 by incubating with
human TLR2-FITC antibody (or an isotype control antibody) at a
concentration of 10 lg/ml, in the presence of goat serum for 30 min
at 4 C. The cells were subsequently washed, ﬁxed in 1% paraformal-
dehyde and analyzed by ﬂow cytometry on an Elite EPICS ﬂuores-
cence-activated cell sorter (Coulter, Hialeah, FL). Data from 10000
cells per condition were recorded to yield the percentage of cells
expressing receptors.2.5. Microarray analysis
Microarray analysis was performed as previously described [10].
Brieﬂy, PBM from four donors were either left untreated, treated with
25 ng/ml human IFNc, or infected with F. novicida at an MOI of 100
for 24 h. IFNc was used at 25 ng/ml since pilot experiments indicated
that higher concentrations of IFNc are toxic to primary human mono-
cytes. RNA from each of these separate treatments was extracted using
TRIzol Reagent (Invitrogen Life Technologies), column-puriﬁed using
RNeasy columns (Qiagen), and then hybridized to Human Genome
U133 Plus 2.0 Array chips (Aﬀymetrix). Expression values were calcu-
lated using the gcrma package in BioConductor (www.bioconduc-
tor.org) and the resulting data were analyzed for diﬀerential
expression using the limma package [13]. Genes with adjusted P values
60.05 were counted as signiﬁcantly diﬀerent. These were ranked by
fold change.blished by Elsevier B.V. All rights reserved.
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3.1. IFNc pretreatment enhances IL-23 production during
Francisella infection
To test whether IFNc could enhance production of IL-23,
we incubated PBM in the presence or absence of recombinant
human IFNc and subsequently infected with F. novicida for
24 h. Cell supernatants were analyzed by ELISA for the pres-
ence of IL-23. The results indicate that IFNc priming leads to
enhanced production of IL-23 in response to F. novicida infec-
tion (Fig. 1A). To examine the inﬂuence of IFNc on the two
subunits of IL-23, supernatants were analyzed by ELISA for
IL-12/23p40 (Fig. 1B) and lysates were analyzed by Western
blotting for the p19 subunit (Fig. 1C). IFNc enhanced the pro-
duction of IL-12/23 p40 subunit but not the p19 subunit in in-
fected PBM. Of note, IFNc alone did not induce the
production of either IL-12/23 p40 nor IL-23. Similar results
were obtained with the THP-1 cells (Fig. 1D–F).0
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Fig. 1. IFNc pretreatment results in enhanced IL-23 production during infe
hIFNc, and subsequently infected for 24 h with F. novicida. Cell supernatants
show data from four donors. Error bars indicate standard deviation. *P valu
(upper panel), followed by a reprobe with actin antibody (lower panel). (D
subsequently infected with F. novicida (MOI of 100). Supernatants and lysa
results are representative of three independent experiments.3.2. F. tularensis LVS elicits a similar IL-23 response
F. tularensis LVS is an attenuated vaccine strain derived
from the Type B holarctica subspecies [14] and is commonly
used to study host response. To test whether these IL-23 ﬁnd-
ings were applicable to this strain, THP-1 cells were infected
with either F. novicida or with F. tularensis LVS for 24 h. Pro-
duction of IL-12/23 p40 and IL-23 was measured by ELISA,
and the p19 subunit was analyzed by Western blotting. Both
strains of the pathogen elicited equivalent responses
(Fig. 2A–C).
The results shown in Fig. 2A–C demonstrate that IL-23 is
produced in response to F. tularensis LVS infection. IFNc
priming resulted in enhanced IL-23 production (Fig. 2D).
IFNc speciﬁcally upregulated the production of IL-12/23p40
but not the p19 subunit (Fig. 2E and F). Indeed, the p19 sub-
unit appeared to be somewhat reduced in the IFNc-treated
cells (Figs. 1 and 2F), perhaps reﬂecting the increased secretion
of IL-23 into the supernatant.Resting
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Fig. 2. F. tularensis LVSelicits a similar IL-23 response. (A–C) THP-1 cells were infected for 24 h with either F. novicida or F. tularensis LVS. Cell
supernatants were assayed by ELISA for IL-12/23 p40 and IL-23, and lysates were analyzed by Western blotting for the p19 subunit. (D–F) THP-1
cells were incubated overnight with 25 ng/ml hIFNc and subsequently infected for 24 h with F. tularensis LVS. Supernatants were assayed by ELISA
for IL-12/23 p40 and IL-23. Data from three independent experiments were analyzed by the students t-test. Error bars indicate standard deviation.
*P value 60.05. Lysates were analyzed by Western blotting for the p19 subunit.
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We recently demonstrated that the production of IL-23 is
dependent on the PI3K/Akt pathway and NFjB [10]. Thus,
THP-1 cells were incubated overnight with or without IFNc
and subsequently infected with F. novicida and analyzed for
phosphorylation of Akt, NFjB and IKKa. The results indi-
cated that all three molecules are phosphorylated in infected
cells (Fig. 3). Interestingly, IFNc priming did not enhance
these upstream signaling events required for cytokine produc-
tion.
Host response to Francisella has been shown to be critically
dependent on the expression of TLR2 [15–18]. Consistent with
a lack of eﬀect on the infection-induced signaling events, IFNc
treatment did not alter TLR2 levels (Fig. 3D).
The enhancement of IL-12 production in IFNc-primed
monocytes has been well documented. Although IFNc alone
does not induce the production of IL-12 p40, it primes the
IL-12 p40 promoter so that transcription can occur in response
to a second stimulus such as LPS. IFNc promotes IL-12 p40
transcription through the induction of IRF-1 and IRF-8/ICS-
BP [19]. Thus, we next examined whether these regulatory fac-
tors were induced in the IFNc-primed PBM. Microarray
analysis of IFNc-primed PBM demonstrated an induction of
both IRF-1 and IRF-8 (8.3-fold change, P = 0.01 and 6.13-fold change, P = 0.0001 for IRF-1 and IRF-8, respectively),
thus accounting for the enhancement in IL-12 p40 production.3.4. IFNc-primed monocytes produce IL-12 p70
IL-12 p70 has been shown to be a strong inducer of IFNc
leading to protection from bacterial infections [20,21,21]. Our
recent studies demonstrated that although IL-12/23 p40 is pro-
duced readily upon Francisella infection of PBM, there was no
detectable IL-12 p70 [10]. Since IFNc has been shown to prime
cells for the production of the p35 subunit [22], we examined
whether IFNc-primed PBM could produce IL-12 p70 in re-
sponse to Francisella infection. For this, IFNc-primed PBM
and mixed peripheral blood mononuclear cells (PBMC) were
infected with F. novicida for 24 h and the cell supernatants were
assayed by ELISA for IL-12 p70. The results demonstrate that
IFNc-primed cells are indeed capable of producing detectable
amounts of IL-12 p70 upon infection (Fig. 4).4. Discussion
The microbicidal activity of monocytes/macrophages is med-
iated by various eﬀectors such as cytokines, and this anti-
IB: Anti-pAkt
IB: Anti-Actin
-I FNγ + IFNγ
R   30’ 2h  5h  R   30’ 2h  5h   
A
B
IB: Anti-Actin
IB: Anti-pIKKα
IB: Anti-pNFκB
-I FNγ + IFNγ
R   30’ 2h  5h  R   30’ 2h  5h   
-I FNγ + IFNγ
R   30’ 2h  5h  R   30’ 2h  5h   
C
D
0
40
80
12
0
16
0
20
0
0 101 102 103 104
FITC
C
ou
nt
s
Control IgG
Anti-TLR2UT
IFN
IB: Anti-Actin
Fig. 3. IFNc-priming does not enhance the activation of the PI3K pathway nor NFjB during infection. THP-1 cells were incubated overnight with
25 ng/ml IFNc and then infected with F. novicida for the time points indicated. Lysates were analyzed by Western blotting with antibodies for the
phosphorylated forms of Akt (A), NFjB (B) or IKKa (C). All membranes were reprobed with actin antibody. These results are representative of
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Fig. 4. IFNc-primed monocytes produce IL-12 p70. (A) PBM and (B) PBMC from three donors were incubated overnight with hIFNc, infected for
24 h with F. novicida and cell supernatants were assayed for IL-12 p70. (C) Proposed model of an ampliﬁcation loop between IL-23 and IFNc.
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the cytokine-enhancing activity of IFNc is an important com-
ponent of IFNc-mediated protection [5,6,8,9,23].
In our previous study we reported that Francisella-infected
PBM secrete IL-23, which can induce secretion of IFNc by
NK cells [10]. Here we show that IFNc priming of monocytes
results in enhanced production of IL-23. Collectively then, ourprevious and present studies suggest that an IL-23 – IFNc loop
may arise upon Francisella infection.
One important point is that IL-12 p70 was only detectable
after IFNc-priming. This suggests that IL-23 may take part
in the early stages of an ampliﬁcation loop, where the resulting
NK cell-derived IFNc feeds back to the monocytes/macro-
phages to elicit IL-12 p70 production. Hence, it is conceivable
1048 J.P. Butchar et al. / FEBS Letters 582 (2008) 1044–1048that IL-23 begins the monocyte – NK cell loop and these initial
iterations of the loop would then result in IL-12 p70 produc-
tion. It is known that IL-12 p70 is far more eﬀective than
IL-23 at eliciting IFNc from NK cells [21], so the secreted
IL-12 p70 would then bring the ampliﬁcation loop to its fullest
level.
One major question is that, given the previous studies show-
ing that IFNc is required for IL-12 p40 production and that
p40 is a subunit of IL-23, how do the monocytes produce
IL-23 to begin with? Our earlier study showed that monocytes
produce small amounts of IFNc during Francisella infection
[10]. This suggests that the IFNc signaling could be at levels
suﬃcient to act in an autocrine/paracrine fashion to enable
p40 production but not yet high enough to elicit p35 produc-
tion. In this sense, the concentration of IFNc could act as a
rheostat, where low levels elicit IL-23 production and high lev-
els elicit more IL-23 but also permit IL-12 p70 production.
In summary, our proposed model (Fig. 4C) shows an initial
relatively weak IFNc response by monocytes to Francisella
infection. This IFNc leads to IL-23 secretion, which then acts
upon NK cells and causes moderate IFNc secretion. The IFNc
then feeds back to the monocytes, prompting them to (1) se-
crete more IL-23 and to (2) begin secreting IL-12 p70. In this
sense, IL-23 is an early yet critical player in the pro-inﬂamma-
tory cytokine loop between monocytes and NK cells, serving
to initiate the stronger IL-12 p70/IFNc ampliﬁcation loop.
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